Jerome B. Zeldis, See Remarks at Sorrento Therapeutics, Inc. (SRNE), bought 10,000 shares at $5.15 ($52K) on 2017-02-03, disclosed to the SEC on 2017-02-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| NXGL | BUY | 2024-08-27 | $25K | — | Filing → |
| PTCT | SELL | 2024-05-24 | $765K | — | Filing → |
| NXGL | BUY | 2023-05-30 | $12K | — | Filing → |